结果：该微球具有良好缓释效果。
Results: The microspheres had a property of sustained drug release.
目的介绍载药中空微球的研究进展。
Objective To review the research progress of drug-loaded hollow microspheres.
门脉系统内未见栓子微球。
采用HPLC法测定微球的体外释放度。
中空微球是一种内部为空腔结构的球形微粒。
Hollow microspheres are a type of microspheres with hollow space inside.
目的制备胸腺五肽微球并对其体外释放进行考察。
OBJECTIVE To prepare thymopentin microspheres and investigate the drug release in vitro.
本文还对三种微球缓释效果的不同原因进行了分析。
The reasons with different release effects were also discussed.
目的考察活性保护剂对微球中蛋白活性的保护作用。
OBJECTIVE to investigate the effect of activity protectors on the protein activity in microspheres.
结果动态透析法能较好地反映微球的实际释药行为。
Result the dynamic dialysis system method could actually reflect the release profile.
一级动力学模型对微球的体外释放情况拟合精度高。
The first order dynamic model could describe the release process in vitro perfectly.
平均生存期A组10.6月、B组7.6月。 顺铂微球加碘化油栓塞的效果明显高于化疗药物碘化油栓塞的效果。
The mean survival time was 10.6 months and 7.6 months in group A and group B respectively.
结论：微导管可脱球囊技术对TCCF是一种微创、安全、有效的治疗方法。
Conclusion: Detachable balloon embolization is a safe and effective method for TCCF.
结论：微导管可脱球囊技术对TCCF是一种微创、安全、有效的治疗方法。
Conclusion: Detachable balloon embolization is a safe and effective method for TCCF.
应用推荐